What is MaxCyte's EV / sales?

MaxCyte (MXCT) reported EV / sales of 2.4× in Q1 2026.

How has MaxCyte's EV / sales changed year-over-year?

MaxCyte's EV / sales decreased by 68.1% year-over-year, from 7.6× to 2.4×.

What is the long-term trend for MaxCyte's EV / sales?

Over 4 years (2021 to 2025), MaxCyte's EV / sales has grown at a -35.9% compound annual growth rate (CAGR), from 29.2× to 4.9×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

MaxCyte MXCT EV / sales

EV / sales at other companies

Bio-Rad LaboratoriesBIO

3.1×+0.1×

Thermo Fisher ScientificTMO

5.1×-0.9×

Ginkgo BioworksDNA

4.3×+2.5×

Rapid Micro BiosystemsRPID

3.3×-0.1×

PDE

Pro-Dex, Inc.PDEX

2.2×-0.4×

RepligenRGEN

12.2×-0.3×

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Calculated from MaxCyte’s reported figures.

enterprise value/total revenue=2.4×

Based on the most recent quarter.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's EV / sales?: MaxCyte (MXCT) reported EV / sales of 2.4× in Q1 2026.
How has MaxCyte's EV / sales changed year-over-year?: MaxCyte's EV / sales decreased by 68.1% year-over-year, from 7.6× to 2.4×.
What is the long-term trend for MaxCyte's EV / sales?: Over 4 years (2021 to 2025), MaxCyte's EV / sales has grown at a -35.9% compound annual growth rate (CAGR), from 29.2× to 4.9×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.